Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS

Leslie Crews, Margaret R. Lentz, R. Gilberto González, Howard S. Fox, Eliezer Masliah

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The success of antiretroviral therapy has reduced the incidence of severe neurological complication resulting from human immunodeficiency virus (HIV) infection. However, increased patient survival has been associated with an increased prevalence of protracted forms of HIV encephalitis leading to moderate cognitive impairment. NeuroAIDS remains a great challenge to patients, their families, and our society. Thus development of preclinical models that will be suitable for testing promising new compounds with neurotrophic and neuroprotective capabilities is of critical importance. The simian immunodeficiency virus (SIV)-infected macaque is the premiere model to study HIV neuropathogenesis. This model was central to the seminal work of Dr. Opendra "Bill" Narayan. Similar to patients with HIV encephalitis, in the SIV model there is injury to the synaptodendritic structure of excitatory pyramidal neurons and inhibitory calbindin-immunoreactive interneurons. This article, which is part of a special issue of the Journal of NeuroVirology in honor of Dr. Bill Narayan, discusses the most important neurodegenerative features in preclinical models of neuroAIDS and their potential for treatment development.

Original languageEnglish (US)
Pages (from-to)327-339
Number of pages13
JournalJournal of neurovirology
Volume14
Issue number4
DOIs
StatePublished - Sep 16 2008

Fingerprint

Simian Immunodeficiency Virus
Animal Models
HIV
Wounds and Injuries
Encephalitis
Calbindins
Pyramidal Cells
Macaca
Interneurons
Virus Diseases
Survival
Neuroaid
Incidence
Therapeutics

Keywords

  • Encephalitis
  • HIV
  • Macaque
  • SIV
  • Transgenic
  • gp120

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Virology

Cite this

Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. / Crews, Leslie; Lentz, Margaret R.; González, R. Gilberto; Fox, Howard S.; Masliah, Eliezer.

In: Journal of neurovirology, Vol. 14, No. 4, 16.09.2008, p. 327-339.

Research output: Contribution to journalReview article

Crews, Leslie ; Lentz, Margaret R. ; González, R. Gilberto ; Fox, Howard S. ; Masliah, Eliezer. / Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS. In: Journal of neurovirology. 2008 ; Vol. 14, No. 4. pp. 327-339.
@article{e47107e33fd24b41b5c4264df0450591,
title = "Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS",
abstract = "The success of antiretroviral therapy has reduced the incidence of severe neurological complication resulting from human immunodeficiency virus (HIV) infection. However, increased patient survival has been associated with an increased prevalence of protracted forms of HIV encephalitis leading to moderate cognitive impairment. NeuroAIDS remains a great challenge to patients, their families, and our society. Thus development of preclinical models that will be suitable for testing promising new compounds with neurotrophic and neuroprotective capabilities is of critical importance. The simian immunodeficiency virus (SIV)-infected macaque is the premiere model to study HIV neuropathogenesis. This model was central to the seminal work of Dr. Opendra {"}Bill{"} Narayan. Similar to patients with HIV encephalitis, in the SIV model there is injury to the synaptodendritic structure of excitatory pyramidal neurons and inhibitory calbindin-immunoreactive interneurons. This article, which is part of a special issue of the Journal of NeuroVirology in honor of Dr. Bill Narayan, discusses the most important neurodegenerative features in preclinical models of neuroAIDS and their potential for treatment development.",
keywords = "Encephalitis, HIV, Macaque, SIV, Transgenic, gp120",
author = "Leslie Crews and Lentz, {Margaret R.} and Gonz{\'a}lez, {R. Gilberto} and Fox, {Howard S.} and Eliezer Masliah",
year = "2008",
month = "9",
day = "16",
doi = "10.1080/13550280802132840",
language = "English (US)",
volume = "14",
pages = "327--339",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS

AU - Crews, Leslie

AU - Lentz, Margaret R.

AU - González, R. Gilberto

AU - Fox, Howard S.

AU - Masliah, Eliezer

PY - 2008/9/16

Y1 - 2008/9/16

N2 - The success of antiretroviral therapy has reduced the incidence of severe neurological complication resulting from human immunodeficiency virus (HIV) infection. However, increased patient survival has been associated with an increased prevalence of protracted forms of HIV encephalitis leading to moderate cognitive impairment. NeuroAIDS remains a great challenge to patients, their families, and our society. Thus development of preclinical models that will be suitable for testing promising new compounds with neurotrophic and neuroprotective capabilities is of critical importance. The simian immunodeficiency virus (SIV)-infected macaque is the premiere model to study HIV neuropathogenesis. This model was central to the seminal work of Dr. Opendra "Bill" Narayan. Similar to patients with HIV encephalitis, in the SIV model there is injury to the synaptodendritic structure of excitatory pyramidal neurons and inhibitory calbindin-immunoreactive interneurons. This article, which is part of a special issue of the Journal of NeuroVirology in honor of Dr. Bill Narayan, discusses the most important neurodegenerative features in preclinical models of neuroAIDS and their potential for treatment development.

AB - The success of antiretroviral therapy has reduced the incidence of severe neurological complication resulting from human immunodeficiency virus (HIV) infection. However, increased patient survival has been associated with an increased prevalence of protracted forms of HIV encephalitis leading to moderate cognitive impairment. NeuroAIDS remains a great challenge to patients, their families, and our society. Thus development of preclinical models that will be suitable for testing promising new compounds with neurotrophic and neuroprotective capabilities is of critical importance. The simian immunodeficiency virus (SIV)-infected macaque is the premiere model to study HIV neuropathogenesis. This model was central to the seminal work of Dr. Opendra "Bill" Narayan. Similar to patients with HIV encephalitis, in the SIV model there is injury to the synaptodendritic structure of excitatory pyramidal neurons and inhibitory calbindin-immunoreactive interneurons. This article, which is part of a special issue of the Journal of NeuroVirology in honor of Dr. Bill Narayan, discusses the most important neurodegenerative features in preclinical models of neuroAIDS and their potential for treatment development.

KW - Encephalitis

KW - HIV

KW - Macaque

KW - SIV

KW - Transgenic

KW - gp120

UR - http://www.scopus.com/inward/record.url?scp=51449106704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51449106704&partnerID=8YFLogxK

U2 - 10.1080/13550280802132840

DO - 10.1080/13550280802132840

M3 - Review article

C2 - 18780234

AN - SCOPUS:51449106704

VL - 14

SP - 327

EP - 339

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 4

ER -